Confluence Wealth Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Buy
+1,191
New +$234K 0.01% 428
2022
Q1
Sell
-637
Closed -$110K 444
2021
Q4
$110K Buy
+637
New +$96.9K 0.04% 319

Other funds holding DGX

Confluence Wealth Services's DGX Position: Q2 2026 in Review

Confluence Wealth Services opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,191 shares worth $252K. The stake represents 0.01% of the portfolio and ranks #428 among its holdings. This is a return to the name: Confluence Wealth Services previously reported a position in DGX as recently as Q4 2021.

Confluence Wealth Services first reported a position in DGX in Q4 2021 and has held it in 2 quarters since. 264 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Confluence Wealth Services held 1,191 shares of Quest Diagnostics worth $252K as of Q2 2026.
  • Quest Diagnostics was a new Confluence Wealth Services position in Q2 2026.
  • Quest Diagnostics made up 0.01% of Confluence Wealth Services's portfolio in Q2 2026, its #428 holding.
  • Confluence Wealth Services first reported a position in Quest Diagnostics in Q4 2021 and has held it in 2 quarters since.
  • 264 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.